GSK announced another batch of positive data from its respiratory program with the investigational drug depemokimab, this time in patients with chronic rhinosinusitis with nasal …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
WASHINGTON — The Biden administration has suspended federal grants issued to EcoHealth Alliance, the infectious disease research group caught up in a controversy over its
A drug used to combat fungal infections in cancer patients comes with a big caveat — research shows the medicine can last twice as long
New research in Scientific Reports reveals that COVID-19 survivors, especially those who had severe or critical illness, face long-term lung complications and a reduced quality